The 2021 CETUS randomised placebo-controlled trial in individuals with new-onset prediabetes after acute pancreatitis showed that mild exogenous ketosis results in a 14.5% reduction in plasma glucose levels and a significant increase in GIP level [52]. This evidence concerns the gene GIP and acute pancreatitis.